Search Results - "Sedlacek, Scot"

Paclitaxel After Doxorubicin Plus Cyclophosphamide As Adjuvant Chemotherapy for Node-Positive Breast Cancer: Results From NSABP B-28 by MAMOUNAS, Eleftherios P, RRYANT, John, LEMBERSKY, Barry, FEHRENBACHER, Louis, SADLACEK, Scot M, FISHER, Bernard, WIRKERHAM, Lawrence, YOTHERS, Greg, SORAN, Atilla, WOLMARK, Norman

“…The primary aim of National Surgical Adjuvant Breast and Bowel Project (NSABP) B-28 was to determine whether four cycles of adjuvant paclitaxel (PTX) after…”
Get full text

Weight loss interventions for breast cancer survivors: impact of dietary pattern by Thompson, Henry J, Sedlacek, Scot M, Playdon, Mary C, Wolfe, Pamela, McGinley, John N, Paul, Devchand, Lakoski, Susan G

“…Body weight management is not emphasized in clinical practice guidelines for breast cancer survivors, reflecting the lack of evidence that weight loss improves…”
Get full text

Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2 -amplified early stage breast cancer: a single-group, open-label, phase 2 study by Jones, Stephen E, Dr, Collea, Rufus, MD, Paul, Devchand, DO, Sedlacek, Scot, MD, Favret, Anne M, MD, Gore, Ira, MD, Lindquist, Deborah L, MD, Holmes, Frankie Ann, MD, Allison, Mary Ann K, MD, Brooks, Barry D, MD, Portillo, Raul M, MD, Vukelja, Svetislava J, MD, Steinberg, Michael S, MD, Stokoe, Christopher, MD, Crockett, Maria W, BS, Wang, Yunfei, PhD, Asmar, Lina, PhD, Robert, Nicholas J, MD, O'Shaughnessy, Joyce, MD

“…Summary Background Previous results suggest that docetaxel plus cyclophosphamide improves disease-free survival (DFS) and overall survival compared with…”
Get full text

A Randomized, Double-Blind, Placebo-Controlled Investigation of Selenium Supplementation in Women at Elevated Risk for Breast Cancer: Lessons for Re-Emergent Interest in Selenium and Cancer by Thompson, Henry J, Sedlacek, Scot M, Fitzgerald, Vanessa K, Wolfe, Pamela, McGinley, John N

“…Damage to cellular macromolecules such as DNA and lipid, induced via reactive oxygen species, and indicators of cell proliferation potential such as…”
Get full text

Impact of Weight Loss on Plasma Leptin and Adiponectin in Overweight-to-Obese Post Menopausal Breast Cancer Survivors by Thompson, Henry J, Sedlacek, Scot M, Wolfe, Pamela, Paul, Devchand, Lakoski, Susan G, Playdon, Mary C, McGinley, John N, Matthews, Shawna B

“…Women who are obese at the time of breast cancer diagnosis have higher overall mortality than normal weight women and some evidence implicates adiponectin and…”
Get full text

Effect of a low fat versus a low carbohydrate weight loss dietary intervention on biomarkers of long term survival in breast cancer patients ('CHOICE'): study protocol by Sedlacek, Scot M, Playdon, Mary C, Wolfe, Pamela, McGinley, John N, Wisthoff, Mark R, Daeninck, Elizabeth A, Jiang, Weiqin, Zhu, Zongjian, Thompson, Henry J

“…Weight loss in overweight or obese breast cancer patients is associated with an improved prognosis for long term survival. However, it is not clear whether the…”
Get full text

Impact of a Commercial Reference Laboratory Test Recurrence Score on Decision Making in Early-Stage Breast Cancer by Oratz, Ruth, Paul, Dev, Cohn, Allen L, Sedlacek, Scot M

“…New York University School of Medicine, New York, NY; Rocky Mountain Cancer Centers–US Oncology Research Network, Denver, CO Corresponding author: Ruth Oratz,…”
Get full text

Effect of dietary patterns differing in carbohydrate and fat content on blood lipid and glucose profiles based on weight-loss success of breast-cancer survivors by Thompson, Henry J, Sedlacek, Scot M, Paul, Devchand, Wolfe, Pamela, McGinley, John N, Playdon, Mary C, Daeninck, Elizabeth A, Bartels, Sara N, Wisthoff, Mark R

“…Healthy body weight is an important factor for prevention of breast cancer recurrence. Yet, weight loss and weight gain are not currently included in…”
Get full text

Effect of increased vegetable and fruit consumption on markers of oxidative cellular damage by Thompson, Henry J., Heimendinger, Jerianne, Haegele, Albert, Sedlacek, Scot M., Gillette, Cynthia, O'neill, Caitlin, Wolfe, Pamela, Conry, Colleen

“…The goal of this study was to test the hypothesis that increased consumption of vegetables and fruit would reduce markers of oxidative cellular damage that can…”
Get full text

In Vivo Investigation of Changes in Biomarkers of Oxidative Stress Induced by Plant Food Rich Diets by Thompson, Henry J, Heimendinger, Jerianne, Gillette, Cynthia, Sedlacek, Scot M, Haegele, Albert, O'Neill, Caitlin, Wolfe, Pamela

“…It is well established that vegetables and fruit (VF) contain antioxidant phytochemicals. Consequently, it is expected that individuals who consume diets with…”
Get full text

Clinical Experience With Image-Guided Radiotherapy in an Accelerated Partial Breast Intensity-Modulated Radiotherapy Protocol by Leonard, Charles E., M.D, Tallhamer, Michael, M.S, Johnson, Tim, Ph.D, Hunter, Kari, C.M.D, Howell, Kathryn, M.D, Kercher, Jane, M.D, Widener, Jodi, M.D, Kaske, Terese, M.D, Paul, Devchand, M.D, Sedlacek, Scot, M.D, Carter, Dennis L., M.D

“…Purpose To explore the feasibility of fiducial markers for the use of image-guided radiotherapy (IGRT) in an accelerated partial breast intensity modulated…”
Get full text

Phase III Multicenter Trial of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel Compared With Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel As Adjuvant Therapy for Women With High-Risk Breast Cancer by LOESCH, David, GRECO, F. Anthony, PIPPEN, John, LINDQUIST, Deborah, MCINTYRE, Kristi, BLUM, Joanne L, MODIANO, Manuel R, BOEHM, Kristi A, FENG ZHAN, ASMAR, Lina, ROBERT, Nicholas, SENZER, Neil N, BURRIS, Howard A, HAINSWORTH, John D, JONES, Stephen, VUKELJA, Svetislava J, SANDBACH, John, HOLMES, Frankie, SEDLACEK, Scot

“…This study compared disease-free survival (DFS) obtained with two different regimens of adjuvant therapy in high-risk breast cancer. Women (who had performance…”
Get full text

Predictors for Clinical Outcomes After Accelerated Partial Breast Intensity-Modulated Radiotherapy by Reeder, Reed, Carter, Dennis L., M.D, Howell, Kathryn, M.D, Henkenberns, Phyllis, O.C.N, Tallhamer, Michael, M.S, Johnson, Tim, Ph.D, Kercher, Jane, M.D, Widner, Jodi, M.D, Kaske, Terese, M.D, Paul, Devchand, D.O., M.D, Sedlacek, Scot, M.D, Leonard, Charles E., M.D

“…Purpose To correlate the treatment planning parameters with the clinical outcomes in patients treated with accelerated partial breast intensity-modulated…”
Get full text

Plasma Xanthophyll Carotenoids Correlate Inversely with Indices of Oxidative DNA Damage and Lipid Peroxidation by HAEGELE, A. D, GILLETTE, C, O'NEILL, C, WOLFE, P, HEIMENDINGER, J, SEDLACEK, S, THOMPSON, H. J

“…Post hoc analysis of data obtained from a study designed to modulate oxidative damage by dietary intervention revealed consistently strong inverse correlations…”
Get full text

Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine by O'Shaughnessy, Joyce, Koeppen, Hartmut, Xiao, Yuanyuan, Lackner, Mark R, Paul, Devchand, Stokoe, Christopher, Pippen, Jr, John, Krekow, Lea, Holmes, Frankie Ann, Vukelja, Svetislava, Lindquist, Deborah, Sedlacek, Scot, Rivera, Ragene, Brooks, Robert, McIntyre, Kristi, Brownstein, Carrie, Hoersch, Silke, Blum, Joanne L, Jones, Stephen

“…We conducted a randomized phase III study to determine whether patients with early breast cancer would benefit from the addition of capecitabine (X) to a…”
Get full text

Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus‐Associated Stomatitis: A Randomized Phase II Study by Jones, Vicky E., McIntyre, Kristi J., Paul, Devchand, Wilks, Sharon T., Ondreyco, Sharon M., Sedlacek, Scot, Melnyk, Anton, Oommen, Sanjay P., Wang, Yunfei, Peck, Susan R., O'Shaughnessy, Joyce A.

“…Background Mammalian target of rapamycin (mTOR) inhibitor‐associated stomatitis (mIAS) is a frequent adverse event (AE) associated with mTOR inhibitor therapy…”
Get full text

Abstract P4-12-08: Utilizing next generation sequencing technologies for hereditary breast cancer risk assessments in a private oncology practice by Hamlington, Barbara, Sedlacek, Scot, Langer, Lucy, Goetsch, Brittney, Lemas, Katie, Diab, Sami

“…Abstract Background: The recent introduction of clinical Next Generation Sequencing (NGS) technologies has transformed the ability of health care providers to…”
Get full text

Can telephone counseling post-treatment improve psychosocial outcomes among early stage breast cancer survivors? by Marcus, Alfred C., Garrett, Kathleen M., Cella, David, Wenzel, Lari, Brady, Marianne J., Fairclough, Diane, Pate-Willig, Meredith, Barnes, Denise, Powell Emsbo, Susan, Kluhsman, Brenda C., Crane, Lori, Sedlacek, Scot, Flynn, Patrick J.

“…Objective: To determine whether a telephone counseling program can improve psychosocial outcomes among breast cancer patients post‐treatment. Methods: A…”
Get full text

Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast Cancer by Osborne, Cynthia, Challagalla, Jagathi D., Eisenbeis, Charles F., Holmes, Frankie Ann, Neubauer, Marcus A., Koutrelakos, Nicholas W., Taboada, Carlos A., Vukelja, Sasha J., Wilks, Sharon T., Allison, Mary Ann, Reddy, Praveen, Sedlacek, Scot, Wang, Yunfei, Asmar, Lina, O’Shaughnessy, Joyce

“…The combination of ixabepilone and carboplatin was investigated in a phase II study of 103 patients with hormone receptor-positive (HR+) and triple negative…”
Get full text

8-Isoprostane F2α excretion is reduced in women by increased vegetable and fruit intake by Thompson, Henry J, Heimendinger, Jerianne, Sedlacek, Scot, Haegele, Albert, Diker, Ann, O’Neill, Caitlin, Meinecke, Becky, Wolfe, Pamela, Zhu, Zongjian, Jiang, Weiqin

Get full text